AllDocs -> heart diseases

All Records First Record Next Record Make PDF Universität Zürich > Vetsuisse-Fakultät > Veterinärbakteriologie, Institut für > PD Dr. Richard Hoop Summary / Zusammenfassung Arteriosclerosis is a disease of ageing psittacines. In the literature the significance of infectious agents in the pathogenesis of this disease is controversially discussed. In human medicine the presence of Chlamydophila pneumoniae in arteriosclerotic lesions has been reported several times. The causative agent of Marek disease, a herpesvirus, can cause arteriosclerosis in male poultry. Recently a new group of minuscule organisms has been found in human arteria with sclerotic alterations. This project will use molecular methods to look at fresh and formaline-fixed material with arteriosclerosis . Psittacine arteriosclerosis : presence of Chlamydophila spp, herpesvirus or nanoorganisms? Project ...

7 A t the April ATVB Leadership Committee meeting, the group participated in a council strategic planning session facilitated by Steve Strucely, director of business planning at the National Center. The session was held to identify challenges and opportunities and formulate goals and objectives for the next three years. The strategic planning process follows a path of three steps: knowledge discovery (focus on research efforts), knowledge processing (put research knowledge into an applicable form) and knowledge transfer (disseminate the information). Based on member responses, the facilitator provided a summary of the ATVB “SWOT” analysis grid identifying council strengths, weaknesses, opportunities and threats. Goals and supporting strategies have since been determined to address council programs and activities; membership and involvement; ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology T he Council on Arteriosclerosis , Thrombosis, and Vascular Biology Merit Awards for Young Investigators • encourages and supports the efforts of early career investigators in cardiovascular research, and • encourages early career investigators, women and under- represented minorities to partici- pate in ATVB and AHA activities. These awards provide travel funding to assist invited abstract presenters in attending the AHA’s Scientific Sessions each November. Eligibility Criteria: • All applicants for travel grants must be members of the AHA/ASA at any level. • Applicants must be active in research and still be in training as an undergraduate or pre-doctoral student, or a fellow who has completed training only within the last five years; ...

Please visit us online at: http://aha.medcareers.com Or visit ATVB online at: http://atvb.ahajournals.org/ F OR I NFORMATION AND A D P LACEMENT C ONTACT : J ENNIFER W ILLIAMS A RTERIOSCLEROSIS , T HROMBOSIS , AND V ASCULAR B IOLOGY L IPPINCOTT W ILLIAMS & W ILKINS 351 W EST C AMDEN S TREET B ALTIMORE , MD 21201-2436 T ELEPHONE : 1-800-528-1843 OR 410-528-4049 F AX : 410-528-4452 E- MAIL : jennifer.m.williams@wolterskluwer.com B ...

J Chin Med Assoc • January 2006 • Vol 69 • No 1 14 ORIGINAL ARTICLE Introduction Guidelines for the management of cardiovascular risk factors 1–3 and diseases 4,5 have been well established, based on massive series of randomized control trials that showed significant impact on cardiovascular outcomes. Therefore, it is generally agreed that the major barrier to effective cardiovascular prevention is not the lack of evidence but the lack of motivation to follow the guidelines. 6–8 It remains true that strict performance of the guidelines may improve the outcomes of stable patients with cardiovascular risk factors and/or diseases. 7 Prevalence of Arteriosclerosis and Atherosclerosis in Stable Patients at a Cardiovascular Outpatient Clinic: Potential for Better Care Hao-Min Cheng 1 ...

Accession information: Vol. 5; 30 September 2003 ©2003 Cambridge University Press http://www.expertreviews.org/ Potential mechanisms by which isoflavones protect against arteriosclerosis 1 expert reviews in molecular medicine Table 2. Potential mechanisms by which isoflavones protect against arteriosclerosis Isoflavone property Mechanisms Antioxidant activity Inhibition of low-density lipoprotein (LDL) oxidation Stimulation of antioxidant enzymes Induction of glutathione (GSH) synthesis Hypocholesterolaemic effects Increased bile acid secretion Increased LDL receptor activity Reduced cholesterol absorption from gut Gene-regulatory activity Inhibition of NF- ? B-dependent signal transduction pathways Inhibition of protein tyrosine kinase activity Inhibition of inducible nitric oxide production ...

ATVB orchestrated a full complement of basic and translational scientific sessions in Dallas. • Two Sunday Morning Programs explored links among atherosclerosis, restenosis and angiogenesis and provided updates in lipid and thrombosis science. • Daily 90-minute late-afternoon Cardiovascular Seminars covered a variety of topics in the ATVB scientific purview. • Edward F. Plow, PhD, of the Cleveland Clinic Foundation, gave The Sol Sherry Distinguished Lecture in Thrombosis, entitled “Regulation of Coagulation and Fibrinolyis,” on Monday afternoon. • Elizabeth G. Nabel, MD, director of the National Heart, Lung, and Blood Institute, discussed “Stem Cells in Atherosclerosis” in the Russell Ross Memorial Lecture on Vascular Biology. • Donald D. Heistad, MD, of the University of Iowa, gave the George L. Duff Memorial Lecture on “Oxidant Signaling in Health ...

Last/family name __ First/given name Middle initial Hospital/institution _ Degree __ Street address _This is: ? Business ? Home City _ State Country Zip/postal code Phone Fax _ (Area/country code/city code) (Area/country code/city code) E-mail address _ AHA Membership No. This information is for your badge. Please print clearly. Registration Fees On or before After Professional AHA Members March 27, 2006 March 27, 2006 A __ Premium Professional Member US $300 US $350 B __ General Professional Member US $400 US $450 C __ Premium Emeritus Member US $125 US $175 D __ Early Career Member US $300 US $350 E __ Trainee/Fellow/Student/Technician* US $125 US $175 Professional Nonmembers F __ Nonmember US $400 US $450 G __ Early Career Nonmember US $400 US $450 H __ T...

GENERAL INFORMATION Issuance _ Frequency: Monthly Issue date, mail class, mailing cover: second to last Friday of previous month, periodicals class, polywrapped with mailing card Established __ January 1981 Editorial Content __ Arteriosclerosis , Thrombosis, and Vascular Biology presents original research and reviews on the biology, prevention, and impact of vascular diseases. Editorial features include: Original Contributions, Reviews, Meeting Summaries, and the AHA News and Meetings Calendar. Arteriosclerosis , Thrombosis, and Vascular Biology is ranked #3 in “impact factor” among all journals in the Peripheral Vascular Disease category, (ISI, 2004). Editor Donald D. Heistad, MD University of Iowa, College of Medicine Subscription Data __ Rates: Members (US) Premium Professional: $217 General ...

ATVB Fellowship Nomination Form Revised November 2004 Page 1 of 3 Council on Arteriosclerosis , Thrombosis and Vascular Biology Fellowship Nomination Form Purpose of Fellowship - Fellowship provides a means to recognize and award leadership within the American Heart Association / American Stroke Association relative to cardiovascular diseases and stroke. Eligibility - Fellowship is open to both scientists working in the area of arteriosclerosis , thrombosis, and vascular biology and to clinical professionals engaged in diagnosis and management of patients with arteriosclerosis or thrombotic disease. To be eligible for Fellowship, candidates must be active Premium Professional members of the AHA Council on Arteriosclerosis , Thrombosis and Vascular Biology at the time of nomination (active member is described as a member whose dues are current): Criteria – Candidates ...

T he causal mechanisms of the strong inverse relationship of plasma levels of high density lipoprotein (HDL) cholesterol and the major HDL protein apoA-1 with risk of atherosclerotic cardiovascular disease is complex and highly dependent on the dynamic metabolism of HDL. Unlike the metabolism of apoB-containing lipoproteins, the individual lipid and apolipoproteins components of HDL are largely assembled extracellularly and catabolized independently of each other. Therefore, careful dissection of the pathways of both HDL apolipoprotein and HDL lipid metabolism is critical to understanding the physiological mechanisms by which HDL protects against atherosclerosis. Despite major advances in the cellular and molecular biology and biochemistry of processes such as cellular cholesterol efflux, lipase modification of HDL, and selective uptake of HDL cholesterol, ...

1 Council on Arteriosclerosis , Thrombosis and Vascular Biology (ATVB) 2005-2006 Leadership Committee Chairperson Linda Curtiss PhD FAHA 06/2006 Professor Scripps Research Institute 10550 N. Torrey Pines Road La Jolla, CA 92037-1000 Phone (858) 784-8248 Fax (858) 784-9144 Email lcurtiss@scripps.edu Vice-Chairperson Alan Daugherty PhD DSc FAHA 06/2008 Professor of Medicine and Physiology University of Kentucky Cardiovascular Research Center 900 S. Limestone St. CT Wethington Buidling, Room 521 Lexington, KY 40536-0001 Phone (859) 323-4933 Ext. 81389 Fax (859) 257-3646 Email alan.daugherty@uky.edu Chair, Fall Program Committee and Co-Chair, Page Committee Members Thomas Bersot MD PhD FAHA 06/2007 Gladstone Institute San Francisco 1650 Owens Street San Francisco, CA 94103 ...

Diseases of the Circulatory System University of San Francisco Dr. M. Maag ©2004 Margaret Maag 2 Class 8: Cardiac Objectives n Upon completion of this lesson, the student will be able to n Distinguish between arteriosclerosis and atherosclerosis; describe the formation and consequences of atheromatous plaque. n Determine the etiology and treatment of hypertension. n Distinguish between primary and secondary hypertension and identify classifications of hypertension for adults n Determine risk factors and signs/symptoms associated with CAD, PVD and DVTs. Formulate nursing interventions for CAD. n Compare and contrast the etiology and manifestations of myocarditis and pericarditis with a classmate. n Identify the types of angina and arrhythmias associated with myocardial ischemia ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology D r. Elizabeth G. Nabel, fellow and former Chairperson of ATVB (2002–03), has been appointed Director of the National Heart, Lung, and Blood Institute (NHLBI) effective Feb. 1, 2005, succeeding Dr. Claude Lenfant, who retired in August 2003 after 21 years as NHLBI Director. Dr. Nabel received her undergraduate education at Wellesley College and her MD from Cornell Medical College. She completed internship, internal medicine residency, and clinical and research fellowships in cardiovascular medicine at the Brigham and Women’s Hospitals of Harvard University. She then joined the University of Michigan, where her research centered upon the molecular genetics of cardiovascular disease. She advanced to chief of cardiology before moving ...

An innovative technology determines arterial stiff- ness within 2 minutes at a patient’s home by using a simple upper-arm cuff. The augmentation index (AIX), ejection duration (ED), pulse wave velocity (PWV), blood pressure (BP) and heart rate (HR) data are transmitted via standard telephone lines to the care centre for further analysis. The solution is now used for long-term telemedical monitoring of arterial stiffness. Though several methods are known to stratify car- diovascular (CV) risk, it has been shown that the assessment of the arterial age by measuring the arte- rial stiffness of the large arteries provides valuable information. These parameters have independent prognostic value beyond Framingham or other known risk-scoring methods. Furthermore, the non-invasive measurements of AIX and PWV pro- vide information about the level of arteriosclerosis of the large arteries. Stiff ...

NOTES Advances in the Pharmacologic Treatment of Arteriosclerosis : What Does the Future Hold? Kim J. Hodgson, MD, Springfield, IL 31st Global: Vascular and Endovascular Issues, Techniques and Horizons™ he typical orificial location of renal artery occlu- sive lesions, coupled with the relative intolerance of the kidney to ischemia and embolization, render the endovascular treatment of these vessels perhaps the most technically challenging of all endovascular procedures. Comprehensive catheter/guidewire skills are essential for safe performance of these proce- dures, as the margin for error is small. Nonetheless, since operative management of these conditions also carries substantial risks, renal angioplasty, with or without stenting, has earned a prominent place in the armamentarium of options to revascularize effected kidneys. The role for endovascular treatment of these ...

NOTES Advances in the Pharmacologic Treatment of Arteriosclerosis : What Does the Future Hold? Russell H. Samson, MD, FACS, RVT, Sarasota, FL 31st Global: Vascular and Endovascular Issues, Techniques and Horizons™ he last 10 years has seen an explosion in our knowledge about atherosclerosis and its risk fac- tors and management. Research initiatives are now being directed at lowering low-density lipoprotein (LDL), raising high-density lipoprotein (HDL), rais- ing apolipoprotein A (apo A), and lowering athero- sclerotic risk by polypharmacy. It is now conceivable that pharmacologic and preventive health measures may actually eradicate the disease that is the founda- tion of our specialty. Lowering LDL Statins are now the most commonly prescribed class of drugs in developed nations, and in the United Kingdom, simvastatin is now available as an over-the- counter ...

113 Journal dentaire du Québec Volume 42 Mars 2005 Editorial Denis Forest, DDS Editor in Chief Ischemic cardiac disease and cerebral vascular accidents are among the major causes of morbidity throughout the world. Their prevalence should increase in the upcoming years due to the increase in global malnutrition and poor lifestyles. However, arteriosclerosis is not a new disease as it has been known since time in memorial. These accidents come as a result of a rupture or erosion of arterioslerotic plaque leading to the formation of a thrombus which obstructs the vascular lumen followed by an ischemic accident. Over the last ten years, several studies seem to have shown that a potential risk exists between periodontal disease and cardiovascular diseases such as arteriosclerosis , myocardial infarct, infectious endocarditis and cerebral vascular accidents, ...

10 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology B y most accounts, the ATVB’s annual meeting in San Francisco was a major success. Below appears a short article kindly prepared by Robert Hegele, MD (Robarts Research Institute, London, Ontario) summarizing and illustrating the illuminating translational work he presented in his ATVB Award for Basic Science and Clinical Research Lecture. Juxtaposed is a comment on the meeting content prepared by Kevin Atkins, PhD (Ann Arbor, Michigan), lamenting the under-representation of basic vascular biology presentations at this year’s sessions. These two pieces, one exhibiting the clinical benefit to be derived from application of basic human genetics to human epidemiology and treatment, the other requesting continued emphasis on the “pure” vascular biology underpinnings of ...

10 C o u n c i l o n Arteriosclerosis, Thrombosis and Vascular Biology B y most accounts, the ATVB’s annual meeting in San Francisco was a major success. Below appears a short article kindly prepared by Robert Hegele, MD (Robarts Research Institute, London, Ontario) summarizing and illustrating the illuminating translational work he presented in his ATVB Award for Basic Science and Clinical Research Lecture. Juxtaposed is a comment on the meeting content prepared by Kevin Atkins, PhD (Ann Arbor, Michigan), lamenting the under-representation of basic vascular biology presentations at this year’s sessions. These two pieces, one exhibiting the clinical benefit to be derived from application of basic human genetics to human epidemiology and treatment, the other requesting continued emphasis on the “pure” vascular biology underpinnings of clinical ...

Lipid Levels – The Risk of Arteriosclerosis This material is intended for insurance informati onal purposes only and is not personal medical advice for clients. This marketing material includes an expiration date and use of this material must be discontinued as of the expiration date. FOR INTERNAL USE ONLY. NOT FOR USE WITH THE PUBLIC ©2004 The Prudential Insurance Company of America 751 Broad Street, Newark, NJ 07102-3777 Rx001 IFS-A005217 Ed. 02/04 Exp. 08/05 Cholesterol and triglycerides are fatty substances (lipids) found normally in the blood. A high level of lipids in the bloodstream is called hyperlipidemia and is a major risk factor for coronary heart disease. Hyperlipidemia can affect the heart in this way: Cholesterol and other lipids build up in the inner lining of blood vessels like rust in water pipes and, over time, close these vessels. The narrowing of blood vessels, called ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology Sunday Morning Programs 9:00 AM –12:00 NOON Sponsored by the Council on Arteriosclerosis , Thrombosis and Vascular Biology Translational Science 2004: Biomarkers for Identifying the Patient at Risk and Treating Their Lipid and Thrombotic Disorders • Novel Inflammatory and Thrombotic Biomarkers for Cardiovascular Risk Prediction. CRP and Beyond • Role of Newer Lipid Measurements to Risk Prediction • What Antithrombotics Should Be Taken? • Why Aren’t Patients Treated to the Lipid Guidelines? • Managing Low HDL Patients • ATP-III: Updates and Their Application to the Real World Determinants of Recurrent Coronary Disease: Its Influence in Optimizing Post Discharge in ACS • Plaque Vulnerability and its Prothrombotic ...

Final Program 5th Annual Conference on Arteriosclerosis , Thrombosis and Vascular Biology May 6–8, 2004 Hilton San Francisco San Francisco, CA Conference sponsored by the American Heart Association’s Scientific Council on Arteriosclerosis , Thrombosis and Vascular Biology; Council on Nutrition, Physical Activity and Metabolism; and the National Heart, Lung, and Blood Institute. For online information, see www.myamericanheart.org/conferences Email: scientificconferences@heart.org Page 2 The American Heart Association gratefully acknowledges educational grants provided by the following companies: AstraZeneca Pharmaceuticals Boehringer Ingelheim Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership Centocor Eli Lilly and Company Merck/Schering-Plough Pharmaceuticals Merck & Co., Inc. ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology T he 5th Annual Conference on Arteriosclerosis , Thrombosis, and Vascular Biology will be held at the Hilton San Francisco, May 6–8, 2004. The meeting is sponsored by the ATVB Council; the Council on Nutrition, Physical Activity and Metabolism; and the National Heart, Lung, and Blood Institute. The conference will include special lectures, discussions, and oral and poster presentations. Plenary presentations will be made by leading investigators in a variety of fields, spanning platelet and vascular cell signaling, lipid trafficking and lipoprotein metabolism, atherosclerosis and thrombosis, obesity, extracellular matrix biology, and leukocyte biology and inflammation. Special events include the Irvine H. Page Young Investigator Research Award Competition, ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology P articipants in the 76th Annual Scientific Sessions of the American Heart Association held Nov. 8–11 in Orlando found an enormous trove of scientific and clinical data as well as inspirational lectures, practical advice and a spectacular array of pharmaceutical, device, and literature exhibits. They also discovered that ATVB Council members figured prominently among awardees, special lecture speakers, plenary session presenters, press conference discussants and motivational speakers for special sessions on cardiovascular science and medicine trainees. Awarded the American Heart Association’s Basic Research Prize during the meeting’s opening session were Shaun R. Coughlin, MD, PhD, and David Ginsburg, MD, for their axis- shifting contributions to the fields of vascular biology and coagulation. ...

Editorial Homocysteine, Marfan Syndrome and arteriosclerosis Kilmer S. McCully* Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Boston Healthcare System, 1400 Veterans of Foreign Wars Parkway, West Roxbury MA 02132, USA Received 30 June 2003; accepted 4 July 2003 See doi:10.1016/j.ehj.2003.08.020, for the article to which this editorial refers Homocystinuria is an inherited disease of homocysteine metabolism most commonly caused by deficiency of the pyridoxal phosphate-dependent enzyme, cystathionine synthase. The disease is manifested in many cases by accelerated growth in childhood, dislocated ocular lenses, skeletal abnormalities, retarded mental develop- ment, and propensity to thrombosis with increased mortality from vascular disease. 1 Before the discovery of homocystinuria in 1962, many ...

Preliminary Program/Call for Abstracts 5th Annual Conference on Arteriosclerosis , Thrombosis and Vascular Biology May 6–8, 2004 Hilton San Francisco San Francisco, CA S p o n s o red by the American Heart Association Scientific Council on Arteriosclerosis , Thrombosis and Vascular Biology; Council on Nutrition, Physical Activity and Metabolism; and the National Heart, Lung, and Blood Institute. For online information, visit us at www.myamericanheart.org Email: scientificconferences@heart.org Page 2 We appreciate the educational grant from the National Heart, Lung, and Blood Institute to support the New Investigator Travel Awards. Additionally, we thank Bristol-Myers Squibb Company and Pfizer/Parke Davis for their contribution in support of the Jeffrey M. Hoeg Arteriosclerosis , Thrombosis and Vascular Biology Award ...

Measurement of Local Pulse Wave Velocity in Arteriosclerosis by Ultrasonic Doppler Method Noriyoshi Chubachit , Hiroshi Kanait , Ryoji Muratat, and Yoshiro Koiwat +Department of Electrical Engineering, Faculty of Eng., Tohoku University, Sendai 980-77, Japan *First Dept. of Internal Medicine, School of Medicine, Tohoku University, Sendai 980-77, Japan Abstract-This paper presents a new method to mea- sure local pulse wave velocity (PWV), which is an in- dex of the hardness in the range of several millimeters on the aortic wall for diagnosis of the early stage ar- teriosclerosis. Small vibration signals are measured si- multaneously at two adjacent points on the aortic wall near the aortic valve by electronically alternating the direction of an ultrasonic beam. ...

6 C o u n c i l o n Arteriosclerosis , Thrombosis and Vascular Biology ATVB Oral Sessions November 9 3:45 PM –5:00 PM • Regulation of Smooth Muscle Cell Gene Expression — Rm 304CD • Nitric Oxide in Atherosclerosis — Rm 304AB • Myocardial and Vascular Regeneration — Rm 303 • Pro-Inflammatory Effects of C-Reactive Protein — Rm 304EF • Regulation of Platelet Function — Rm 304GH • Oxidant Signaling — Rm 206 • The Broad Spectrum of Mutations Associated with Arrhythmias — Rm 209 November 10 8:30 AM –11:45 AM • Chemokines and Cytokines in Atherosclerosis — Rm 304AB • Endothelial Cell Signaling and Functional Implications — Rm 304CD • Remodeling of Damaged Vascular and Cardiac Tissue — Rm 304EF • Featured Research: Regulation of Angiogenesis in Models ...